Ingelheim, Germany and Indianapolis, US, 16 September, 2014 – Boehringer Ingelheim and Eli Lilly and Company today presented results from a 52-week Phase III study ...

The new diabetes test helps identify patients with type 1 diabetes The FDA has approved empagliflozin/linagliptin tablets as an adjunct to diet and exercise to ...

The investigational combination tablet of empagliflozin and linagliptin reduced blood glucose levels in patients with type 2 diabetes as presented by Boehringer Ingelheim and Eli Lilly and Company at ...

GLYXAMBI is not recommended in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. GLYXAMBI has not been studied in patients with a history of pancreatitis, and it is unknown ...

Credit: Shutterstock. The Food and Drug Administration (FDA) has approved Trijardy XR (Boehringer Ingelheim and Lilly) as an adjunct to diet and exercise to improve glycemic control in adults with ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Whether already on metformin or drug-naive, patients ...

Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration (FDA) for empagliflozin and linagliptin tablets, 10 mg/5 mg and 25 mg/5 mg (USRLD: ...

Zydus Lifesciences Ltd announced that it has secured tentative approval from the United States Food and Drug Administration (FDA) for empagliflozin and linagliptin tablets. These shall be available in ...

The Multidisciplinary Committee (MDC) of experts with the National Pharmaceutical Pricing Authority (NPPA) has recommended retail price of combinations containing diabetes drug empagliflozin, for ...

Oral semaglutide, a tablet-based GLP-1 receptor agonist drug, has performed stronger in achieving weight loss and reduction in HbA1c than empagliflozin in a new trial. The results come from the ...

RIDGEFIELD, Conn. and INDIANAPOLIS, June 15, 2014 -- Two phase III clinical trials found the investigational combination tablet of empagliflozin and linagliptin reduced blood glucose levels in adults ...

- For those taking metformin, empagliflozin/linagliptin combination tablet showed statistically significant reductions in blood glucose vs. empagliflozin or ...